Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2009-04-01 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MANDELIEU-LA-NAPOULE (06210), Alpes-Maritimes
PHARMACIE DU MARCO POLO : revenue, balance sheet and financial ratios
PHARMACIE DU MARCO POLO is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MANDELIEU-LA-NAPOULE (06210),
this company of category PME
shows in 2021 a revenue of 3.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU MARCO POLO (SIREN 511167256)
Indicator
2024
2023
2021
2020
2019
2018
2016
Revenue
N/C
N/C
3 451 512 €
3 134 317 €
2 920 282 €
2 746 664 €
2 662 456 €
Net income
160 419 €
5 847 €
180 387 €
130 168 €
163 155 €
136 249 €
155 252 €
EBITDA
N/C
N/C
242 148 €
149 555 €
214 369 €
204 053 €
239 147 €
Net margin
N/C
N/C
5.2%
4.2%
5.6%
5.0%
5.8%
Revenue and income statement
In 2024, PHARMACIE DU MARCO POLO generates positive net income of 160 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 155 k€ -> 160 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
160 419 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 114%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
114.085%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
38.587%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU MARCO POLO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2023
2024
Debt ratio
62.179
27.691
15.671
9.093
3.05
85.25
114.085
Financial autonomy
52.602
67.58
73.362
75.678
78.788
46.588
38.587
Repayment capacity
4.869
2.72
1.465
1.533
0.305
None
None
Cash flow / Revenue
5.653%
5.478%
5.905%
3.298%
5.32%
None%
None%
Sector positioning
Debt ratio
114.082024
2021
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average+40 pts over 3 years
In 2024, the debt ratio of PHARMACIE DU MARCO POLO (114.08) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
38.59%2024
2021
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average-39 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DU MARCO POLO (38.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
0.3 years2021
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Excellent
In 2021, the repayment capacity of PHARMACIE DU MARCO POLO (0.30) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 104.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
104.127
Liquidity indicators evolution PHARMACIE DU MARCO POLO
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2021
2023
2024
Liquidity ratio
146.482
148.853
140.817
145.161
140.656
178.444
104.127
Interest coverage
9.567
4.813
1.062
1.085
2.623
None
None
Sector positioning
Liquidity ratio
104.132024
2021
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of PHARMACIE DU MARCO POLO (104.13) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
2.62x2021
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Good
In 2021, the interest coverage of PHARMACIE DU MARCO POLO (2.6x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU MARCO POLO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2023
2024
Operating WCR
315 208 €
344 432 €
276 259 €
322 709 €
384 844 €
0 €
0 €
Inventory turnover (days)
42
40
36
36
32
0
0
Customer payment term (days)
7
6
5
9
13
0
0
Supplier payment term (days)
44
42
43
43
46
0
0
Positioning of PHARMACIE DU MARCO POLO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DU MARCO POLO is estimated at
2 239 567 €
(range 1 559 599€ - 3 350 521€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1559k€2239k€3350k€
2 239 567 €Range: 1 559 599€ - 3 350 521€
NAF 5 année 2024
Valuation method used
Net Income Multiple
160 419 €
×
14.0x
=2 239 568 €
Range: 1 559 600€ - 3 350 522€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU MARCO POLO with other companies in the same sector:
Frequently asked questions about PHARMACIE DU MARCO POLO
What is the revenue of PHARMACIE DU MARCO POLO ?
The revenue of PHARMACIE DU MARCO POLO in 2021 is 3.5 M€.
Is PHARMACIE DU MARCO POLO profitable?
Yes, PHARMACIE DU MARCO POLO generated a net profit of 160 k€ in 2024.
Where is the headquarters of PHARMACIE DU MARCO POLO ?
The headquarters of PHARMACIE DU MARCO POLO is located in MANDELIEU-LA-NAPOULE (06210), in the department Alpes-Maritimes.
Where to find the tax return of PHARMACIE DU MARCO POLO ?
The tax return of PHARMACIE DU MARCO POLO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU MARCO POLO operate?
PHARMACIE DU MARCO POLO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart